Clinical trial
Comparison of Trough Level-based Spacing and Clinical-based Spacing of Infliximab Infusions in Patients With Inflammatory Bowel Disease in Deep Remission; A Prospective, Multicenter, Open-label, Randomized, Controlled Study
NCT03841942 is registered in ClinicalTrials.gov with University Hospital, Montpellier as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of Trough Level-based Spacing and Clinical-based Spacing of Infliximab Infusions in Patients With Inflammatory Bowel Disease in Deep Remission; A Prospective, Multicenter, Open-label, Randomized, Controlled Study
- Lead sponsor
- University Hospital, Montpellier
- Phase
- Not applicable
- Overall status
- Terminated
- Start date
- June 26, 2019
- Completion date
- October 31, 2023
- Enrollment
- 64 (actual)
- Sites
- 16
Conditions
As the registry lists them; a condition with its own page is linked.